Depends on how deal is structured. If they are launching Q1 of 2013, big pharma will want to see market response to product/uptake. If good & on-going studies look good...maybe. I'm sure WP will work hard to get a buyer- they made some bad deals that cost WP millions. I just hope the buy-out happens at aggressive PPS so shareholders benefit. SD has 1 million shares in tlon, so my hope is he will push to get top $.